Richard J. Gregory - Net Worth and Insider Trading
Richard J. Gregory Net Worth
The estimated net worth of Richard J. Gregory is at least $7 Million dollars as of 2024-11-13. Richard J. Gregory is the Executive VP & CSO of Immunogen Inc and owns about 236,056 shares of Immunogen Inc (IMGN) stock worth over $7 Million. Details can be seen in Richard J. Gregory's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Richard J. Gregory has not made any transactions after 2019-01-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Richard J. Gregory
Richard J. Gregory Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Richard J. Gregory owns 3 companies in total, including Homology Medicines Inc (FIXX) , Immunogen Inc (IMGN) , and ProMIS Neurosciences Inc (PMN) .
Click here to see the complete history of Richard J. Gregory’s form 4 insider trades.
Insider Ownership Summary of Richard J. Gregory
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
FIXX | Homology Medicines Inc | 2018-03-27 | director |
IMGN | Immunogen Inc | 2019-01-07 | Executive VP & CSO |
PMN | ProMIS Neurosciences Inc | 2022-07-07 | director |
Richard J. Gregory Latest Holdings Summary
Richard J. Gregory currently owns a total of 1 stock. Richard J. Gregory owns 236,056 shares of Immunogen Inc (IMGN) as of January 7, 2019, with a value of $7 Million.
Latest Holdings of Richard J. Gregory
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
IMGN | Immunogen Inc | 2019-01-07 | 236,056 | 31.23 | 7,372,029 |
Holding Weightings of Richard J. Gregory
Richard J. Gregory Form 4 Trading Tracker
According to the SEC Form 4 filings, Richard J. Gregory has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the sale of 3,038 shares on January 7, 2019, which brought Richard J. Gregory around $16,010.
Insider Trading History of Richard J. Gregory
- 1
Richard J. Gregory Trading Performance
GuruFocus tracks the stock performance after each of Richard J. Gregory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Richard J. Gregory is 41.21%. GuruFocus also compares Richard J. Gregory's trading performance to market benchmark return within the same time period. The performance of stocks bought by Richard J. Gregory within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Richard J. Gregory's insider trading performs compared to the benchmark.
Performance of Richard J. Gregory
Richard J. Gregory Ownership Network
Ownership Network List of Richard J. Gregory
Ownership Network Relation of Richard J. Gregory
Richard J. Gregory Owned Company Details
What does Homology Medicines Inc do?
Who are the key executives at Homology Medicines Inc?
Richard J. Gregory is the director of Homology Medicines Inc. Other key executives at Homology Medicines Inc include director & President & CEO Arthur Tzianabos , See Remarks Paul Alloway , and Chief Scientific Officer Albert Seymour .
Homology Medicines Inc (FIXX) Insider Trades Summary
Over the past 18 months, Richard J. Gregory made no insider transaction in Homology Medicines Inc (FIXX). Other recent insider transactions involving Homology Medicines Inc (FIXX) include a net sale of 1,952 shares made by Julie Jordan , a net sale of 13,037 shares made by Arthur Tzianabos , and a net sale of 7,280 shares made by Paul Alloway .
In summary, during the past 3 months, insiders sold 0 shares of Homology Medicines Inc (FIXX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,413 shares of Homology Medicines Inc (FIXX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,413 shares.
Homology Medicines Inc (FIXX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Homology Medicines Inc Insider Transactions
Richard J. Gregory Mailing Address
Above is the net worth, insider trading, and ownership report for Richard J. Gregory. You might contact Richard J. Gregory via mailing address: 830 Winter Street, Waltham Ma 02451.